دورية أكاديمية

Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene.

التفاصيل البيبلوغرافية
العنوان: Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene.
المؤلفون: Kostic M; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Raymond JJ; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Freyre CAC; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Henry B; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Tumkaya T; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States.; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Khlghatyan J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Dvornik J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Li J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Hsiao JS; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Cheon SH; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Chung J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Sun Y; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Dolmetsch RE; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Worringer KA; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Ihry RJ; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States.
المصدر: ACS chemical neuroscience [ACS Chem Neurosci] 2023 Nov 15; Vol. 14 (22), pp. 3993-4012. Date of Electronic Publication: 2023 Oct 30.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101525337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1948-7193 (Electronic) Linking ISSN: 19487193 NLM ISO Abbreviation: ACS Chem Neurosci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, D.C. : American Chemical Society
مواضيع طبية MeSH: DNA Copy Number Variations*/genetics , Chromosome Deletion*, Humans ; Brain ; Phenotype ; Organoids ; RNA Splicing Factors/genetics
مستخلص: Copy number variants (CNVs) that delete or duplicate 30 genes within the 16p11.2 genomic region give rise to a range of neurodevelopmental phenotypes with high penetrance in humans. Despite the identification of this small region, the mechanisms by which 16p11.2 CNVs lead to disease are unclear. Relevant models, such as human cortical organoids (hCOs), are needed to understand the human-specific mechanisms of neurodevelopmental disease. We generated hCOs from 17 patients and controls, profiling 167,958 cells with single-cell RNA-sequencing analysis, which revealed neuronal-specific differential expression of genes outside the 16p11.2 region that are related to cell-cell adhesion, neuronal projection growth, and neurodevelopmental disorders. Furthermore, 16p11.2 deletion syndrome organoids exhibited reduced mRNA and protein levels of RBFOX1, a gene that can also harbor CNVs linked to neurodevelopmental phenotypes. We found that the genes previously shown to be regulated by RBFOX1 are also perturbed in organoids from patients with the 16p11.2 deletion syndrome and thus identified a novel link between independent CNVs associated with neuronal development and autism. Overall, this work suggests convergent signaling, which indicates the possibility of a common therapeutic mechanism across multiple rare neuronal diseases.
References: Cell. 2015 May 21;161(5):1202-1214. (PMID: 26000488)
Cell. 2006 Aug 25;126(4):663-76. (PMID: 16904174)
Front Cell Neurosci. 2021 Jan 13;14:611379. (PMID: 33519384)
Hum Mol Genet. 2012 Oct 1;21(19):4171-86. (PMID: 22730494)
Hum Mol Genet. 2013 Nov 15;22(22):4485-501. (PMID: 23813976)
Nature. 2017 May 4;545(7652):48-53. (PMID: 28445462)
Mol Cytogenet. 2015 Aug 16;8:66. (PMID: 26279679)
Nature. 2016 Aug 11;536(7615):205-9. (PMID: 27487209)
Nat Biotechnol. 2009 Mar;27(3):275-80. (PMID: 19252484)
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15672-7. (PMID: 26644564)
Cell Stem Cell. 2019 Oct 3;25(4):558-569.e7. (PMID: 31474560)
Mol Psychiatry. 2017 Jun;22(6):836-849. (PMID: 27240531)
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3196-201. (PMID: 14963232)
Nat Genet. 2017 Jan;49(1):27-35. (PMID: 27869829)
Genomics Proteomics Bioinformatics. 2023 Feb;21(1):190-202. (PMID: 35680096)
Nat Methods. 2015 Jul;12(7):671-8. (PMID: 26005811)
Nature. 2018 Aug;560(7719):494-498. (PMID: 30089906)
J Neurodev Disord. 2010 Mar;2(1):26-38. (PMID: 21731881)
Dev Growth Differ. 2012 Apr;54(3):277-86. (PMID: 22524601)
Hum Brain Mapp. 2016 Aug;37(8):2833-48. (PMID: 27219475)
BMC Bioinformatics. 2013 Apr 15;14:128. (PMID: 23586463)
Biol Psychiatry. 2014 Mar 1;75(5):378-85. (PMID: 23992924)
Cell. 2019 Dec 12;179(7):1469-1482.e11. (PMID: 31835028)
OMICS. 2012 May;16(5):284-7. (PMID: 22455463)
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17076-81. (PMID: 21969575)
Psychiatr Genet. 2020 Oct;30(5):136-140. (PMID: 32732550)
Neuron. 2013 Jun 5;78(5):785-98. (PMID: 23764284)
Nature. 2020 Feb;578(7793):142-148. (PMID: 31996853)
Mol Cytogenet. 2016 Jun 27;9:51. (PMID: 27354858)
Am J Hum Genet. 2012 Jul 13;91(1):38-55. (PMID: 22726847)
Int Rev Neurobiol. 2013;113:251-67. (PMID: 24290388)
Cell Rep. 2017 Dec 5;21(10):2678-2687. (PMID: 29212016)
Annu Rev Pathol. 2015;10:111-44. (PMID: 25621659)
Am J Psychiatry. 2021 Jan 1;178(1):77-86. (PMID: 33384013)
Nat Rev Neurosci. 2007 Jun;8(6):427-37. (PMID: 17514196)
Cell Rep. 2014 May 22;7(4):1077-1092. (PMID: 24794428)
Transl Psychiatry. 2016 Sep 13;6(9):e891. (PMID: 27622935)
Development. 2014 Jun;141(11):2182-94. (PMID: 24866113)
Nat Neurosci. 2021 Apr;24(4):584-594. (PMID: 33723434)
Nat Neurosci. 2010 Jun;13(6):690-9. (PMID: 20436478)
Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):303-13. (PMID: 24700553)
PLoS Genet. 2017 Aug 25;13(8):e1006940. (PMID: 28841651)
Nature. 2010 Mar 25;464(7288):554-561. (PMID: 20154730)
Cold Spring Harb Perspect Med. 2019 Nov 1;9(11):. (PMID: 31427284)
Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
Nature. 2013 Sep 19;501(7467):373-9. (PMID: 23995685)
Eur J Med Genet. 2013 Sep;56(9):484-9. (PMID: 23832105)
Genet Med. 2013 Jun;15(6):478-81. (PMID: 23258348)
Transl Psychiatry. 2019 Jan 16;9(1):8. (PMID: 30664628)
Front Neurol. 2020 Aug 11;11:639. (PMID: 32849171)
Elife. 2020 Nov 10;9:. (PMID: 33169669)
Curr Protoc. 2021 Mar;1(3):e90. (PMID: 33780170)
Cell Rep. 2020 Feb 11;30(6):1682-1689.e3. (PMID: 32049002)
Cell. 2015 Jul 16;162(2):375-390. (PMID: 26186191)
Nat Rev Neurosci. 2013 Nov;14(11):755-69. (PMID: 24105342)
Front Pediatr. 2018 Jun 05;6:163. (PMID: 29922639)
Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658)
Nat Biotechnol. 2018 Jun;36(5):411-420. (PMID: 29608179)
NPJ Genom Med. 2019 Oct 7;4:26. (PMID: 31602316)
Development. 2004 Jul;131(13):3133-45. (PMID: 15175243)
Cell. 2016 May 19;165(5):1238-1254. (PMID: 27118425)
Mol Psychiatry. 2021 Dec;26(12):7560-7580. (PMID: 34433918)
Nature. 2017 May 4;545(7652):54-59. (PMID: 28445465)
Nat Neurosci. 2004 Feb;7(2):136-44. (PMID: 14703572)
Nat Commun. 2021 May 18;12(1):2897. (PMID: 34006844)
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):906-20. (PMID: 20732627)
Nat Genet. 2022 Nov;54(11):1630-1639. (PMID: 36280734)
Nature. 2019 Jun;570(7762):523-527. (PMID: 31168097)
N Engl J Med. 2008 Feb 14;358(7):667-75. (PMID: 18184952)
Cell Stem Cell. 2016 May 5;18(5):591-6. (PMID: 27038591)
JAMA Psychiatry. 2013 Mar;70(3):253-60. (PMID: 23325106)
J Med Genet. 2010 Mar;47(3):195-203. (PMID: 19755429)
Nature. 2008 Oct 16;455(7215):903-11. (PMID: 18923512)
PLoS One. 2013 Sep 06;8(9):e73323. (PMID: 24039908)
Biol Psychiatry. 2015 May 1;77(9):785-93. (PMID: 25064419)
Trends Neurosci. 2014 Jun;37(6):334-42. (PMID: 24745669)
Nucleic Acids Res. 2020 Jan 8;48(D1):D845-D855. (PMID: 31680165)
Psychiatry Investig. 2020 Mar;17(3):256-261. (PMID: 32151128)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Cell Stem Cell. 2008 Nov 6;3(5):519-32. (PMID: 18983967)
Cell. 2007 Nov 30;131(5):861-72. (PMID: 18035408)
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7. (PMID: 27141961)
Nat Neurosci. 2012 Feb 05;15(3):477-86, S1. (PMID: 22306606)
PLoS Genet. 2016 Feb 12;12(2):e1005709. (PMID: 26872257)
J Med Genet. 2010 May;47(5):332-41. (PMID: 19914906)
Am J Hum Genet. 2022 Oct 6;109(10):1789-1813. (PMID: 36152629)
J Neurodev Disord. 2015;7(1):26. (PMID: 26257835)
J Transl Med. 2018 Jul 17;16(1):198. (PMID: 30016977)
Hum Mol Genet. 2008 Feb 15;17(4):628-38. (PMID: 18156158)
Nat Genet. 2009 Nov;41(11):1223-7. (PMID: 19855392)
Nat Commun. 2017 Jan 16;8:14049. (PMID: 28091601)
Trends Neurosci. 2020 Nov;43(11):886-901. (PMID: 32993859)
Sci Rep. 2016 Aug 02;6:30805. (PMID: 27481563)
Mol Syst Biol. 2019 Jun 19;15(6):e8746. (PMID: 31217225)
Neuron. 2019 Sep 4;103(5):785-801.e8. (PMID: 31303374)
Curr Opin Genet Dev. 2021 Jun;68:49-56. (PMID: 33667823)
فهرسة مساهمة: Keywords: 16p11.2; CNV; RBFOX1; autism; brain organoids; scRNA-seq
المشرفين على المادة: 0 (RBFOX1 protein, human)
0 (RNA Splicing Factors)
SCR Disease Name: 16p11.2 Deletion Syndrome
تواريخ الأحداث: Date Created: 20231030 Date Completed: 20231116 Latest Revision: 20231121
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC10655044
DOI: 10.1021/acschemneuro.3c00442
PMID: 37903506
قاعدة البيانات: MEDLINE
الوصف
تدمد:1948-7193
DOI:10.1021/acschemneuro.3c00442